Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity

FEMS Immunology and Medical Microbiology

Volumn 64, Issue 2, 2012, Pages 265-272

  Yuzawa, Satoshi ^a   Kurita Ochiai, Tomoko ^a   Hashizume, Tomomi ^a   Kobayashi, Ryoki ^a   Abiko, Yoshimitsu ^a   Yamamoto, Masafumi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Hemagglutinin A; Porphyromonas gingivalis; Sublingual immunization

Indexed keywords

GAMMA INTERFERON; HEMAGGLUTININ; HYBRID PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; MALTOSE BINDING PROTEIN; MALTOSE BINDING PROTEIN HEMAGGLUTININ A FUSION PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; LYMPH NODE; MONONUCLEAR CELL; MOUSE; MOUTH INFECTION; NONHUMAN; PORPHYROMONAS GINGIVALIS; PORPHYROMONAS GINGIVALIS INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SALIVARY GLAND; SUBMANDIBULAR GLAND; VACCINATION;

ADMINISTRATION, SUBLINGUAL; ALVEOLAR BONE LOSS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; BACTEROIDACEAE INFECTIONS; CYTOKINES; ESCHERICHIA COLI PROTEINS; FEMALE; IMMUNOGLOBULIN A; LECTINS; LEUKOCYTES, MONONUCLEAR; MALTOSE-BINDING PROTEINS; MICE; MICE, INBRED BALB C; MOUTH; PORPHYROMONAS GINGIVALIS; RECOMBINANT FUSION PROTEINS; SALIVA; VACCINES, SYNTHETIC;

EID: 84856960928     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00895.x     Document Type: Article

References (37)

1. Cuburu N, Kweon MN, Song JH et al. (2007) Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine 25: 8598-8610.
2. Destefano F, Anda RF, Kahn HS, Williamson DF & Russell CM (1993) Dental disease and risk of coronary heart-disease and mortality. Br Med J 306: 688-691.
3. Du Y, Hashizume T, Kurita-Ochiai T, Yuzawa S, Abiko Y & Yamamoto M (2011) Nasal immunization with a fusion protein consisting of the hemagglutinin A antigenic region and the maltose-binding protein elicits CD11c(+) CD8(+) dendritic cells for induced long-term protective immunity. Infect Immun 79: 895-904.
4. Fernandez S, Palmer DR, Simmons M et al. (2007) Potential role for toll-like receptor 4 in mediating Escherichia coli maltose-binding protein activation of dendritic cells. Infect Immun 75: 1359-1363.
5. Fox JD, Kapust RB & Waugh DS (2001) Single amino acid substitutions on the surface of Escherichia coli maltose-binding protein can have a profound impact on the solubility of fusion proteins. Protein Sci 10: 622-630.
6. Hashizume T, Togawa A, Nochi T, Igarashi O, Kweon MN, Kiyono H & Yamamoto M (2008) Peyer's patches are required for intestinal immunoglobulin A responses to Salmonella spp. Infect Immun 76: 927-934.
7. Holt SC, Kesavalu L, Walker S & Genco CA (1999) Virulence factors of Porphyromonas gingivalis. Periodontol 2000 2000: 168-238.
8. Klausen B, Evans RT & Sfintescu C (1989) Two complementary methods of assessing periodontal bone level in rats. Scand J Dent Res 97: 494-499.
9. Kobayashi T, Kaneko S, Tahara T, Hayakawa M, Abiko Y & Yoshie H (2006) Antibody responses to Porphyromonas gingivalis hemagglutinin A and outer membrane protein in chronic periodontitis. J Periodontol 77: 364-369.
10. Koizumi Y, Kurita-Ochiai T, Oguchi S & Yamamoto M (2008) Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice. Infect Immun 76: 2958-2965.
11. Krejci CB (1996) Osteoporosis and periodontal disease: is there a relationship? J West Soc Periodontol Periodontal Abstr 44: 37-42.
12. Lee SW, Hillman JD & Progulske-Fox A (1996) The hemagglutinin genes hagB and hagC of Porphyromonas gingivalis are transcribed in vivo as shown by use of a new expression vector. Infect Immun 64: 4802-4810.
13. Lépine G, Ellen RP & Progulske-Fox A (1996) Construction and preliminary characterization of three hemagglutinin mutants of Porphyromonas gingivalis. Infect Immun 64: 1467-1472.
14. Liu C, Hashizume T, Kurita-Ochiai T, Fujihashi K & Yamamoto M (2010) Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity. Mol Oral Microbiol 25: 178-189.
15. Maeba S, Otake S, Namikoshi J, Shibata Y, Hayakawa M, Abiko Y & Yamamoto M (2005) Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis. Vaccine 23: 2513-2521.
16. McSorley SJ & Garside P (1999) Vaccination by inducing oral tolerance? Immunol Today 20: 555-560.
17. Mestecky J, Husby S, Moldoveanu Z, Waldo FB, van den Wall Bake AW & Elson CO (1996) Induction of tolerance in humans: effectiveness of oral and nasal immunization routes. Ann N Y Acad Sci 778: 194-201.
18. Momoi F, Hashizume T, Kurita-Ochiai T, Yuki Y, Kiyono H & Yamamoto M (2008) Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies. Infect Immun 76: 2777-2784.
19. Mutsch M, Zhou W, Rhodes P et al. (2004) Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 350: 896-903.
20. Offenbacher S, Katz V, Fertik G et al. (1996) Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 67: 1103-1113.
21. Reddy MS (2002) Oral osteoporosis: is there an association between periodontitis and osteoporosis? Compend Contin Educ Dent 23: 21-28.
22. Rico AI, Del Real G, Soto M, Quijada L, Martinez AC, Alonso C & Requena JM (1998) Characterization of the immunostimulatory properties of Leishmania infantum HSP70 by fusion to the Escherichia coli maltose-binding protein in normal and nu/nu BALB/c mice. Infect Immun 66: 347-352.
23. Riggs P (2000) Expression and purification of recombinant proteins by fusion to maltose-binding protein. Mol Biotechnol 15: 51-63.
24. Roeder LB & Dennison DK (1998) Diabetes and periodontal disease. J Gt Houst Dent Soc 70: 13-15.
25. Routzahn KM & Waugh DS (2002) Differential effects of supplementary affinity tags on the solubility of MBP fusion proteins. J Struct Funct Genomics 2: 83-92.
26. Seong SY, Huh MS, Jang WJ et al. (1997) Induction of homologous immune response to Rickettsia tsutsugamushi Boryong with a partial 56-kilodalton recombinant antigen fused with the maltose-binding protein MBP-Bor56. Infect Immun 65: 1541-1545.
27. Shibata Y, Hayakawa M, Takiguchi H, Shiroza T & Abiko Y (1999) Determination and characterization of the hemagglutinin-associated short motifs found in Porphyromonas gingivalis multiple gene products. J Biol Chem 274: 5012-5020.
28. Song H, Bélanger M, Whitlock J, Kozarov E & Progulske-Fox A (2005) Hemagglutinin B is involved in the adherence of Porphyromonas gingivalis to human coronary artery endothelial cells. Infect Immun 73: 7267-7273.
29. Song JH, Nguyen HH, Cuburu N et al. (2008) Sublingual vaccination with influenza virus protects mice against lethal viral infection. P Natl Acad Sci USA 105: 1644-1649.
30. Song JH, Kim JI, Kwon HJ et al. (2009) CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination. J Immunol 182: 6851-6860.
31. Squier CA (1991) The permeability of oral mucosa. Crit Rev Oral Biol Med 2: 13-32.
32. Suyama T, Hayakawa M & Abiko Y (2004) Subcloning of the 200-kDa Porphyromonas gingivalis antigen gene and inhibition of hemagglutination by an antibody against the recombinant protein. J Oral Sci 46: 163-169.
33. van Ginkel FW, Jackson RJ, Yuki Y & McGhee JR (2000) Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 165: 4778-4782.
34. Yamamoto M, McDaniel LS, Kawabata K, Briles DE, Jackson RJ, McGhee JR & Kiyono H (1997) Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection. Infect Immun 65: 640-644.
35. Zhang H, Zhang J & Streisand JB (2002) Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 41: 661-680.
36. Zhang T, Hashizume T, Kurita-Ochiai T & Yamamoto M (2009) Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity. Biochem Biophys Res Commun 390: 937-941.
37. Zhu S, Yang G, Yang X et al. (2009) Soluble expression in Escherichia coli of active human cyclic nucleotide phosphodiesterase isoform 4B2 in fusion with maltose-binding protein. Biosci Biotechnol Biochem 73: 968-970.